Bionic Pancreas in CFRD

Description

This multi-center randomized controlled trial (RCT) will compare efficacy and safety endpoints using the insulin-only configuration of the iLet Bionic Pancreas System (BP) versus a control group using their usual care insulin delivery method and continuous glucose monitoring (CGM) during a 13-week study period in individuals ≥14 years old with cystic fibrosis-related diabetes (CFRD). After 13 weeks, participants will continue in a 13-week Extension Phase in which the BP group will continue to use the BP system and the Usual Care group will initiate use of the BP system.

Conditions

Cystic Fibrosis-related Diabetes

Study Overview

Study Details

Study overview

This multi-center randomized controlled trial (RCT) will compare efficacy and safety endpoints using the insulin-only configuration of the iLet Bionic Pancreas System (BP) versus a control group using their usual care insulin delivery method and continuous glucose monitoring (CGM) during a 13-week study period in individuals ≥14 years old with cystic fibrosis-related diabetes (CFRD). After 13 weeks, participants will continue in a 13-week Extension Phase in which the BP group will continue to use the BP system and the Usual Care group will initiate use of the BP system.

A Randomized Trial of the Insulin-only Bionic Pancreas in Cystic Fibrosis Related Diabetes

Bionic Pancreas in CFRD

Condition
Cystic Fibrosis-related Diabetes
Intervention / Treatment

-

Contacts and Locations

Aurora

University of Colorado-Barbara Davis Center for Diabetes, Aurora, Colorado, United States, 80045

Boston

Massachusetts General Hospital, Boston, Massachusetts, United States, 02114

Minneapolis

University of Minnesota, Minneapolis, Minnesota, United States, 55455

Kansas City

Children's Mercy Hospital, Kansas City, Missouri, United States, 64108

Cleveland

University Hospitals of Cleveland, Cleveland, Ohio, United States, 44106

Philadelphia

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States, 19104

Charlottesville

University of Virginia-Center for Diabetes Technology, Charlottesville, Virginia, United States, 22903

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    14 Years to

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    Jaeb Center for Health Research,

    Melissa Putman, MD, STUDY_CHAIR, Massachusetts General Hospital

    Colleen Bauza, PhD, MPH, STUDY_DIRECTOR, Jaeb Center for Health Research

    Study Record Dates

    2026-03